Authored by: Chris Fox, Executive Vice President, U.S. Commercial, and Head of Innovative Franchise at Teva
The journey to better health for millions of Americans is rarely a simple one. It’s a deeply personal, often complex path with challenges of diagnosis, access and the realities of living with a condition. As an industry, we face a collective responsibility to make healthcare more intuitive, more equitable and fundamentally more human.
At Teva, we embrace this challenge head-on. Our perspective, which we call the human side of medicine, shapes our every decision, innovation and collaboration. It means truly seeing the person impacted by every prescription or treatment.
This commitment is how we strive to redefine commercial excellence across the full spectrum of medicine, from essential generics to innovative therapies and a diverse portfolio of biosimilars. It’s what drives us to combine scale with agility, compassion with data and expertise with accountability, and the engine behind our ‘Pivot to Growth’ strategy which has fueled eleven consecutive quarters of growth.
Navigating the Patient Journey: Solutions for Systemic Barriers
The patient journey is a powerful roadmap to understanding where the healthcare system falls short. From initial awareness to sustained treatment, it’s no secret that barriers can impede access to necessary care. We believe true commercial excellence means addressing these systemic challenges as a model for how to meet patient needs more effectively, from common conditions to rare diseases.
This conviction is evident in Teva’s comprehensive approach across the continuum of care:
- Transforming care in key therapeutic areas: We recognize the critical unmet needs in areas like central nervous system (CNS) conditions and immunology, leading us to advance innovative therapies spanning mental health, to migraine, to movement. Our deep immersion in the patient journey drives us to explore solutions for conditions like schizophrenia and migraine, designed to improve adherence and quality of life.
- Expanding access and affordability: Teva’s portfolio with a range of complex generics and biosimilars provides diverse pathways to more accessible medicines. We prioritize therapies that serve patient need and drive value in the market, from the first-ever generic GLP-1 medication indicated for weight loss to a portfolio and partnerships in biosimilars that expand access to high-quality biologics for new patient populations spanning oncology to inflammatory conditions to rare diseases.
- Meeting patients where they are: We believe access isn't just about price; it’s also about reach. From collaborations with non-profit organizations such as our Mental Health Access Program to expand behavioral-health services and address gaps in care, to co-pay initiatives and access programs providing therapies at low or no cost to uninsured patients, we implement solutions to get treatments into patients’ hands.
The Engine of Progress: Empowered People & Purpose-Driven Innovation at Teva
Meaningful change in healthcare requires a culture of relentless inquiry, deep collaboration and empowerment. Our people are Teva’s greatest asset, driven by a limitless mindset that fosters bold decisions and original solutions for unmet medical needs with speed and precision. We cultivate talent across the organization, providing opportunities to tackle complex challenges and expand expertise and leadership, all while staying closely connected to the patient journey.
At Teva, our performance-driven culture and commitment to excellence creates an environment where our people are motivated to deliver and empowered to contribute their unique skills and knowledge. By linking expertise across functions, insights in one area quickly become breakthroughs in another.
Beyond new molecules, Teva’s innovation lies in how we leverage information. We’re pragmatic about technology, strategically integrating advanced analytics and AI to streamline processes, operationalize insights and accelerate medicine delivery. This rigorous application of data, from optimizing clinical trials with digital biomarkers to streamlining operations, delivers tangible and measurable impact that helps us serve patients effectively.
A Future Shaped by Purpose: Accelerating Toward Better Health
Our ‘Pivot to Growth’ strategy has propelled us through a period of sustained growth, but momentum is only building. We’re in the midst of acceleration: expanding our innovative portfolio, improving access to medicines through our diversified generics and biosimilars products, and deepening our commitment to patients, while consistently optimizing how we operate.
For us, commercial excellence isn’t merely about market performance; it’s about the responsibility to ensure every therapy we pursue enables better health. If patients have a need, we’re already working to address it.
We believe leadership is not defined by a title but by the actions we take every day. In serving others with humility across all levels of our organization, we empower with accountability to enable agility and efficient, high-quality decision-making.
We continuously raise the bar for innovation, access and meaningful patient impact. This is the standard we hold ourselves to every day, and the reason I’m proud to work alongside this talented group of teams that make up Teva’s U.S. commercial organization, creating a future where patient needs always come first.
At the heart of everything we do, we are on the human side of medicine
Learn more at TevaUSA.com.